Aquipta 10mg and 60mg tablets
*Company:
AbbVie LimitedStatus:
UpdatedLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Updated on 16 October 2024
File name
Aquipta-60mg-10mg-smpc-initial _ELEVATE_10Oct24.pdf
Reasons for updating
- Change to section 5.1 - Pharmacodynamic properties
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Update to section 5.1 - Pharmacodynamic properties, following results from the ELEVATE study.
Updated on 30 April 2024
File name
Aquipta-60mg-10mg-pl-initial MAA_11Aug23.pdf
Reasons for updating
- New PIL for new product
Updated on 30 April 2024
File name
Aquipta-60mg-10mg-smpc-initial MAA_11Aug23.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)